Treating or preventing diabetic retinopathy, using retinal pericyte apoptosis inhibitor, specifically antioxidant or phosphatidylcholine phospholipase C, acid sphingomyelinase or caspase inhibitor

摘要

The use of a retinal pericyte apoptosis inhibitor (I) is claimed in the production of a medicament for treating or preventing diabetic retinopathy. An Independent claim is included for pharmaceutical compositions containing (I).